Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Renovacor to advance AAV gene therapy program for arrhythmogenic cardiomyopathy

July 13, 2022

Tenaya sets out rationale for targeting HDAC6 in heart failure

July 12, 2022

Murine model resembles cardiovascular disease seen in NAFLD

July 12, 2022

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present SLC9A3 inhibitors

July 8, 2022

Bayer discovers soluble guanylate cyclase activators

July 4, 2022

Cardiac myosin inhibitors described by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

June 22, 2022

Cytokine promotes heart repair after infarct

June 20, 2022

Blood vessel shape predicts what shape the heart is in

June 16, 2022

Scientists discover new mechanism that causes cardiac hypertrophy in response to pressure overload

June 15, 2022

Chinese researchers disclose cardiac myosin inhibitors

June 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...